Nalwa Sons [NSIL] vs Capital [CAPINVIT] Detailed Stock Comparison
Nalwa Sons
NSE
Loading...
Capital
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Nalwa Sons wins in 10 metrics, Capital wins in 6 metrics, with 0 ties. Nalwa Sons appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Nalwa Sons | Capital | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 79.37 | 17.08 | Capital |
| Price-to-Book Ratio | 0.20 | 2.25 | Nalwa Sons |
| Debt-to-Equity Ratio | 0.00 | 271.81 | Nalwa Sons |
| PEG Ratio | -6.78 | N/A | N/A |
| EV/EBITDA | -150.91 | 462.28 | Nalwa Sons |
| Profit Margin (TTM) | 35.33% | 8.40% | Nalwa Sons |
| Operating Margin (TTM) | 88.31% | 33.37% | Nalwa Sons |
| EBITDA Margin (TTM) | 88.31% | 33.37% | Nalwa Sons |
| Return on Equity | 0.28% | 11.96% | Capital |
| Return on Assets (TTM) | 0.25% | 6.61% | Capital |
| Free Cash Flow (TTM) | $616.94M | $2.84B | Capital |
| Dividend Yield | N/A | 31.41% | N/A |
| 1-Year Return | 56.53% | -19.21% | Nalwa Sons |
| Price-to-Sales Ratio (TTM) | 28.06 | 1.47 | Capital |
| Enterprise Value | $-150.61B | $59.61B | Capital |
| EV/Revenue Ratio | -122.78 | 3.98 | Nalwa Sons |
| Gross Profit Margin (TTM) | 88.84% | N/A | N/A |
| Revenue per Share (TTM) | $235 | $43 | Nalwa Sons |
| Earnings per Share (Diluted) | $84.42 | $-6.42 | Nalwa Sons |
| Beta (Stock Volatility) | 0.04 | N/A | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Nalwa Sons vs Capital Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Nalwa Sons | 1.09% | 1.09% | -6.69% | -1.54% | 26.43% | -15.11% |
| Capital | 0.11% | 1.29% | 1.69% | -8.09% | -19.33% | -19.21% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Nalwa Sons | 56.53% | 354.05% | 725.84% | 988.46% | 485.31% | 1,364.96% |
| Capital | -19.21% | -19.21% | -19.21% | -19.21% | -19.21% | -19.21% |
Performance & Financial Health Analysis: Nalwa Sons vs Capital
| Metric | NSIL | CAPINVIT |
|---|---|---|
| Market Information | ||
| Market Cap | ₹34.42B | ₹22.04B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 5,943 | 11,302 |
| 90 Day Avg. Volume | 6,686 | 10,199 |
| Last Close | ₹6,773.00 | ₹80.08 |
| 52 Week Range | ₹4,280.45 - ₹9,974.00 | ₹74.26 - ₹109.99 |
| % from 52W High | -32.09% | -27.19% |
| All-Time High | ₹9,974.00 (Nov 18, 2024) | ₹109.99 (Mar 03, 2025) |
| % from All-Time High | -32.09% | -27.19% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.06% | N/A |
| Quarterly Earnings Growth | -0.12% | N/A |
| Financial Health | ||
| Profit Margin (TTM) | 0.35% | 0.08% |
| Operating Margin (TTM) | 0.88% | 0.33% |
| Return on Equity (TTM) | 0.00% | 0.12% |
| Debt to Equity (MRQ) | 0.00 | 271.81 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹33,546.94 | ₹35.59 |
| Cash per Share (MRQ) | ₹36,094.73 | ₹4.87 |
| Operating Cash Flow (TTM) | ₹271.55M | ₹1.10B |
| Levered Free Cash Flow (TTM) | ₹467.15M | ₹-1,938,401,280 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 31.41% |
| Last 12-Month Dividend | N/A | ₹24.95 |
Valuation & Enterprise Metrics Analysis: Nalwa Sons vs Capital
| Metric | NSIL | CAPINVIT |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 79.37 | 17.08 |
| Forward P/E | N/A | N/A |
| PEG Ratio | -6.78 | N/A |
| Price to Sales (TTM) | 28.06 | 1.47 |
| Price to Book (MRQ) | 0.20 | 2.25 |
| Market Capitalization | ||
| Market Capitalization | ₹34.42B | ₹22.04B |
| Enterprise Value | ₹-150,614,474,752 | ₹59.61B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | -122.78 | 3.98 |
| Enterprise to EBITDA | -150.91 | 462.28 |
| Risk & Other Metrics | ||
| Beta | 0.04 | N/A |
| Book Value per Share (MRQ) | ₹33,546.94 | ₹35.59 |
Financial Statements Comparison: Nalwa Sons vs Capital
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | NSIL | CAPINVIT |
|---|---|---|
| Revenue/Sales | ₹99.19M | N/A |
| Cost of Goods Sold | ₹5.66M | N/A |
| Gross Profit | ₹93.54M | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹-307.74M | N/A |
| EBITDA | ₹-302.99M | N/A |
| Pre-Tax Income | ₹-303.05M | N/A |
| Income Tax | ₹-38.59M | N/A |
| Net Income (Profit) | ₹-264.46M | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | NSIL | CAPINVIT |
|---|---|---|
| Cash & Equivalents | ₹26.08M | ₹2.30B |
| Total Current Assets | ₹4.30B | ₹13.49B |
| Total Current Liabilities | ₹15.50M | ₹2.11B |
| Long-Term Debt | N/A | ₹23.16B |
| Total Shareholders Equity | ₹167.24B | ₹23.04B |
| Retained Earnings | N/A | ₹-3.87B |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | NSIL | CAPINVIT |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | NSIL | CAPINVIT |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 5,943 | 11,302 |
| Average Daily Volume (90 Day) | 6,686 | 10,199 |
| Shares Outstanding | 5.14M | 275.40M |
| Float Shares | 1.40M | 200.72M |
| % Held by Insiders | 0.70% | 0.00% |
| % Held by Institutions | 0.03% | 0.13% |
Dividend Analysis & Yield Comparison: Nalwa Sons vs Capital
| Metric | NSIL | CAPINVIT |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹24.95 |
| Last 12-Month Dividend Yield | N/A | 31.41% |
| 3-Year Avg Annual Dividend | N/A | ₹8.32 |
| 3-Year Avg Dividend Yield | N/A | 9.75% |
| 3-Year Total Dividends | N/A | ₹24.95 |
| Ex-Dividend Date | N/A | Aug 11, 2025 |